TFEB and diabetic kidney disease: Hou et al. found that hepatocyte growth factor improved lysosome function by promoting TFEB nuclear translocation via the PI3K/Akt-GSK3β-TFEB axis in podocytes, which decreased urinary albumin excretion, alleviated matrix expansion, and rescued podocyte loss in DKD mice (Fig. 2)76.